|1.||Zhang, Li-Cai: 3 articles (11/2015 - 04/2011)|
|2.||Wang, Chun-Guang: 3 articles (11/2015 - 04/2011)|
|3.||Ding, Yan-Ling: 2 articles (11/2015 - 05/2013)|
|4.||Liu, He: 2 articles (05/2013 - 04/2011)|
|5.||Wei, Jing-Qiu: 2 articles (05/2013 - 04/2011)|
|6.||Hao, Shi: 1 article (11/2015)|
|7.||Liu, Xin: 1 article (11/2015)|
|8.||Guo, Shu-Qin: 1 article (11/2015)|
|9.||Song, Si-Yuan: 1 article (11/2015)|
|10.||Chen, Na: 1 article (11/2015)|
|1.||Substance Withdrawal Syndrome (Withdrawal Symptoms)
05/01/2013 - "Moreover, selective attenuation of p-ERK5 expression in the CSF-CN by lateral ventricle injection of BIX02188 could significantly relieve morphine withdrawal symptom. "
04/20/2011 - "These findings suggested that activation of the ERK5 signaling pathway might contribute to morphine physical dependence and its specific pharmacological inhibitor BIX02188 could be a potential therapeutic choice for alleviation of morphine withdrawal symptoms in the future."
04/20/2011 - "Moreover, selective attenuation of spinal p-ERK5 expression by BIX02188 could significantly relieve morphine withdrawal symptom, accompanying with the decreased phosphorylation of cAMP response-element binding protein (CREB) in the spinal cord. "
|2.||Wounds and Injuries (Trauma)
|1.||Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)
|2.||Morphine (MS Contin)
|3.||salicylhydroxamic acid (SHAM)